Methylfenidaat Hcl 1a Pharma 10 Mg, Tabletten (Methylphenidate Hydrochloride)

Methylphenidate blocks the reuptake transporters for dopamine and norepinephrine in the brain, increasing the levels of these neurotransmitters in the synaptic cleft. The enhanced dopaminergic and noradrenergic signaling improves attention, executive function, and alertness, which underlies its therapeutic effect in ADHD and narcolepsy.

The appropriate dose is individualized and determined by the prescribing clinician based on the patient’s age, severity of symptoms, and response to therapy. Dosage adjustments are made during follow‑up visits to achieve optimal benefit while minimizing adverse effects.

Safety data for methylphenidate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any required temperature control), and assist with import documentation.

Methylfenidaat (methylphenidate) and mixed amphetamine salts are the two primary stimulant classes for ADHD. Methylphenidate primarily blocks dopamine and norepinephrine reuptake, whereas amphetamines increase release of these neurotransmitters in addition to reuptake inhibition. Clinical response varies; some patients tolerate methylphenidate better, while others may achieve greater symptom control with amphetamines. Choice depends on individual efficacy, side‑effect profile, and physician judgment.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer.

The tablet is taken orally, usually once or twice daily, as directed by a prescriber. It should be swallowed whole with a glass of water and can be taken with or without food. Patients should follow the dosing schedule provided by their healthcare professional.

Serious adverse events include cardiovascular complications such as hypertension, tachycardia, or arrhythmias; psychiatric effects like new or worsening psychosis, mania, or severe anxiety; significant growth suppression in children; and rare but severe allergic reactions. Any sudden chest pain, shortness of breath, or unusual behavioral changes should prompt immediate medical evaluation.

The medication is contraindicated in individuals with known hypersensitivity to methylphenidate or any tablet excipients, those with severe cardiovascular disease (e.g., recent myocardial infarction, uncontrolled hypertension), glaucoma, or a history of tics or Tourette syndrome that may be exacerbated. It should also be avoided in patients who have taken monoamine oxidase inhibitors within the past 14 days.